For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
We aimed for excellence: Reflections on a Cornerstone of general practice
+Print Archive
ETCETERA
We aimed for excellence: Reflections on a Cornerstone of general practice
Wednesday 24 October 2018, 03:30 AM

Some indicators had a clear patient benefit... others were a slog we had to get through because they were there
In which the practice has a celebratory beer and curry in hopes it has finally scaled the RNZCGP’s quality heights
Our Cornerstone assessment is done. We’re awaiting the official word, but the feedback on the day suggested we met the requirements.
We started thi, Cornerstone
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.